Latest 30 News in the Life Sciences Industry
GlobeNewswire
Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed
21 Jul 2026
PR Newswire Association LLC.
Takeda's Dengue Vaccine (TAK-003) Becomes India's First Approved Dengue Vaccine, Bringing Prevention to One of the World's Most At-Risk Populations
21 Jul 2026
GlobeNewswire
Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly
21 Jul 2026
GlobeNewswire
Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)
20 Jul 2026
PR Newswire Association LLC.
BioLineRx and Hemispherian AS to Present Data Demonstrating Strong Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancers at ESMO 2026
20 Jul 2026
PR Newswire Association LLC.
Lundbeck announces last patient randomized in DEEp OCEAN, a large Phase III trial in developmental and epileptic encephalopathies (DEEs)
20 Jul 2026
GlobeNewswire
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
20 Jul 2026
PR Newswire Association LLC.
Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
17 Jul 2026
GlobeNewswire
Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026
17 Jul 2026
GlobeNewswire
Orion Corporation’s financial reporting and Annual General Meeting in 2027
17 Jul 2026
GlobeNewswire
Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN
17 Jul 2026
PR Newswire Association LLC.
Getinge Interim Report April-June 2026: Good organic growth, high profitability and strong cash flow
17 Jul 2026
GlobeNewswire
European Commission approves JASCAYD®, bringing well-tolerated, novel oral treatment for IPF and PPF to the EU
17 Jul 2026
PR Newswire Association LLC.
Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad
17 Jul 2026
GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
16 Jul 2026
GlobeNewswire
Boehringer Ingelheim strengthens obesity pipeline as potential first-in-class triple receptor agonist BI 3034701 enters Phase II development
16 Jul 2026
PR Newswire Association LLC.
Sobi Q2 2026 report: Significant growth with important pipeline progress
16 Jul 2026
PR Newswire Association LLC.
Novonesis and TurtleTree enter partnership to support commercialization of lactoferrin
16 Jul 2026
GlobeNewswire
Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved
15 Jul 2026
GlobeNewswire
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026
15 Jul 2026
PR Newswire Association LLC.
HERVolution Therapeutics Presents Clinical Evidence of HERV-K Driving Metabolic Senescence at the International Congress on Obesity 2026
15 Jul 2026
PR Newswire Association LLC.
The Board of Directors of Sobi exercises authorisation for repurchase of shares for the purpose of securing the company's commitments under an incentive programme
15 Jul 2026
PR Newswire Association LLC.
FDA approves Leqembi Iqlik® (lecanemab-irmb) subcutaneous injection as a starting dose for early Alzheimer's disease
14 Jul 2026
PR Newswire Association LLC.
More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026
14 Jul 2026
PR Newswire Association LLC.
Sectra achieves the highest level of security attestation for healthcare providers adopting cloud services in Germany
13 Jul 2026
Upcoming Events All Events
- August 2026
- Online: Biotechgate Digital Partnering August 2026
- September 2026
- Marina Bay Sands: Asia Bio Partnering Forum
- Rockville: BioHealth Capital Region Forum & Investment Conference